Medipharm Anderlecht SRL
2.5 FTEThe score of Medipharm Anderlecht shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +4 % Total assets +3 % Headcount (avg FTE) +150 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Medipharm Anderlecht's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Aug 2026
- Year ended 31 Dec 2024filed on 31 Aug 2025
- Year ended 31 Dec 2023filed on 31 Aug 2024
Medipharm Anderlecht's financial analysis
- Solvency6.3%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Medipharm Anderlecht
Medipharm Anderlecht's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0803.351.426
- VAT number
- BE0803351426
- Peppol
- Registered · 0208:0803351426 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Jun 2023
- Registered office
- 1140 Evere
- Size
- Micro · 2.5 FTE
- Latest accounts
- 2025 · filed on 15 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Medipharm Anderlecht (SRL) has been based in Evere since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 32,003 € and equity of 17,978 €; its revenue is not published. With 2.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 6.3%, below the median of its sector (37.8%).
Companies similar to Medipharm Anderlecht
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie VAN Innis Vincent Retail sale of pharmaceutical products Etterbeek · balance sheet 285,701 €
- Pharma-Seilles Retail sale of pharmaceutical products Andenne · balance sheet 283,948 €
- AONA Retail sale of pharmaceutical products Roeselare · balance sheet 290,456 €
- Theunissen-DE Neve Retail sale of pharmaceutical products Aalst · balance sheet 291,003 €
- LES Iles D'OR Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet 291,796 €
- Askela Retail sale of pharmaceutical products Chièvres · balance sheet 293,294 €
- Aksa Pharma Retail sale of pharmaceutical products Brussels · balance sheet 293,776 €
- Uniper Retail sale of pharmaceutical products Deinze · balance sheet 277,611 €
Frequently asked questions about Medipharm Anderlecht
What is the revenue of Medipharm Anderlecht?
Medipharm Anderlecht files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Medipharm Anderlecht?
In Belgium, the VAT number is the company number prefixed with BE: BE0803351426 for Medipharm Anderlecht, if the company is VAT-registered. Its company number (CBE) is 0803.351.426.
Where is the registered office of Medipharm Anderlecht?
According to the CBE register, the registered office of Medipharm Anderlecht is in 1140 Evere.
What is the equity of Medipharm Anderlecht?
At the close of the 2025 financial year, the equity of Medipharm Anderlecht amounts to 17,978 €, a solvency of 6.3% of total assets.
How many people work at Medipharm Anderlecht?
2.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Medipharm Anderlecht?
The register lists 1 active mandates at Medipharm Anderlecht. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Medipharm Anderlecht
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →